Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
SCIE
SCOPUS
- Title
- Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
- Authors
- 김지혜; 이건주; Seung-Woo Lee
- Date Issued
- 2021-01
- Publisher
- KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
- Abstract
- Clinical trials have demonstrated that an increased number of effector cells, especially tumor-specific T cells, is positively linked with patients' prognosis. Although the discovery of checkpoint inhibitors (CPIs) has led to encouraging progress in cancer immunotherapy, the lack of either T cells or targets for CPIs is a limitation for patients with poor prognosis. Since interleukin (IL)-2 and IL-7 are cytokines that target many aspects of T-cell responses, they have been used to treat cancers. In this review, we focus on the basic biology of how these cytokines regulate T-cell response and on the clinical trials using the cytokines against cancer. Further, we introduce several recent studies that aim to improve cytokines' biological activities and find the strategy for combination with other therapeutics.
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/105199
- DOI
- 10.5483/BMBRep.2021.54.1.257
- ISSN
- 1976-6696
- Article Type
- Article
- Citation
- BMB REPORTS, vol. 54, no. 1, page. 21 - 30, 2021-01
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.